Polar Capital’s Allergan plc AGN Stock Holding History

Polar Capital’s Portfolio AGN Stock Details AGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-171,500	Closed	-$39.6M	–	278
2016 Q2	$39.6M	Buy	171,500 +165,718	+2,866%	+$38.2M	0.75%	37
2016 Q1	$1.55M	Sell	5,782 -97,718	-94%	-$28M	0.03%	222
2015 Q4	$32.3M	Sell	103,500 -67,600	-40%	-$20.1M	0.58%	53
2015 Q3	$46.5M	Buy	+171,100	New	+$52.6M	0.94%	24
2015 Q2	–	Sell	-114,000	Closed	-$33.9M	–	311
2015 Q1	$33.9M	Sell	114,000 -36,000	-24%	-$10.3M	0.64%	51
2014 Q4	$38.6M	Buy	150,000 +27,000	+22%	+$6.75M	0.75%	37
2014 Q3	$29.7M	Buy	123,000 +33,000	+37%	+$7.39M	0.62%	44
2014 Q2	$20.1M	Buy	+90,000	New	+$18.6M	0.43%	80

Other funds holding AGN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Polar Capital's AGN Position: Q3 2016 in Review

Polar Capital sold out of Allergan plc (AGN) in Q3 2016, closing a stake of 171,500 shares — an estimated $39.6M sold.

Polar Capital first reported a position in AGN in Q2 2014 and held it in 8 quarters. The position peaked at $46.5M in Q3 2015. 1,105 funds tracked by Wall St. Rank hold AGN as of Q3 2016.

Polar Capital reported no remaining Allergan plc position as of Q3 2016 after selling out during the quarter.
Polar Capital sold 171,500 Allergan plc shares in Q3 2016, an estimated $39.6M.
Polar Capital first reported a position in Allergan plc in Q2 2014 and held it in 8 quarters.
Polar Capital's Allergan plc position peaked at $46.5M in Q3 2015.
1,105 funds tracked by Wall St. Rank held Allergan plc as of Q3 2016.

Based on Polar Capital's 13F filing for Q3 2016, filed 14 Nov 2016.